0001950047-24-005183.txt : 20240701 0001950047-24-005183.hdr.sgml : 20240701 20240701173536 ACCESSION NUMBER: 0001950047-24-005183 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240701 DATE AS OF CHANGE: 20240701 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 241092040 BUSINESS ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Longpre Lara CENTRAL INDEX KEY: 0001780347 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O MIRUM PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 144 1 primary_doc.xml 144 0001780347 XXXXXXXX LIVE 0001759425 MIRUM PHARMACEUTICALS, INC. 001-38981 989 East Hillsdale Boulevard Suite 300 Foster City CA 94404 (650) 667-4085 LARA LONGPRE Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

30559 1069565.00 47133021 07/01/2024 NASDAQ Common 07/01/2024 Stock Option Exercise Issuer N 30559 07/01/2024 Cash Y 07/01/2024 03/26/2024 /s/ Lara Danielle Longpre